Acorda Appoints Interim CMO
This article was originally published in Scrip
Executive Summary
Acorda Therapeutics Inc. has appointed Burkhard Blank interim chief medical officer (CMO) following news that current CMO Enrique Carrazana is leaving the company – effective Jan. 4, 2016. Blank has served as CMO for various biopharmaceutical companies including Boehringer Ingelheim and as a strategic advisor to a number of biotech companies.